Literature DB >> 33650816

Correlation of sPD1 with Procalcitonin and C-Reactive Protein Levels in Patients with Sepsis.

Zahra Bakhshiani1, Saloomeh Fouladi1, Samaneh Mohammadzadeh2, Nahid Eskandari3,4.   

Abstract

OBJECTIVE: Sepsis results from dysregulated host responses to infection, and it is a major cause of mortality in the world. Co-inhibitory molecules, such as PD-1, play a critical role in this process. Considering the lack of information on the relation between sPD1 and sepsis, the present study aimed to examine the sPD1 level in septic patients and evaluate its correlation with procalcitonin (PCT) and C-reactive protein (CRP) levels.
MATERIALS AND METHODS: This descriptive cross-sectional study consisted of three groups, including septic patients (n=15), suspected of sepsis (n=15), and healthy subjects (n=15). White blood cells (WBCs) and platelet (PLT) counts are evaluated. The serum levels of CRP, PCT, and sPD1 were measured by immunoturbidimetric assay, electrochemiluminescence technology, and the enzyme-linked immunosorbent assay (ELISA), respectively.
RESULTS: Our study indicated that there was a significant difference in WBC and PLT counts between the septic group compared to suspected and control groups (P<0.001, P<0.01, respectively). The CRP level was significantly higher in septic compared to suspected and control groups (P<0.001). There was also a significant difference between the PCT level in septic and suspected groups in comparison with the controls (P<0.001, P<0.01). The sPD1 level was significantly higher in septic patients compared to suspected and control groups (P< 0.001). In septic patients, sPD1 levels were correlated positively with the CRP and PCT levels.
CONCLUSION: Overall, sPD1 correlation with inflammatory markers, might propose it as a potential biomarker to sepsis diagnosis. However, the clinical application of serum sPD-1 testing in patients with sepsis requires further investigation. Copyright© by Royan Institute. All rights reserved.

Entities:  

Keywords:  C-Reactive Protein; Procalcitonin; Sepsis; sPD1

Year:  2021        PMID: 33650816      PMCID: PMC7944127          DOI: 10.22074/cellj.2021.6941

Source DB:  PubMed          Journal:  Cell J        ISSN: 2228-5806            Impact factor:   2.479


  35 in total

1.  Delayed administration of anti-PD-1 antibody reverses immune dysfunction and improves survival during sepsis.

Authors:  Pavan Brahmamdam; Shigeaki Inoue; Jacqueline Unsinger; Katherine C Chang; Jonathan E McDunn; Richard S Hotchkiss
Journal:  J Leukoc Biol       Date:  2010-05-18       Impact factor: 4.962

Review 2.  Biomarkers of sepsis.

Authors:  John C Marshall; Konrad Reinhart
Journal:  Crit Care Med       Date:  2009-07       Impact factor: 7.598

3.  Recognizing Sepsis as a Global Health Priority - A WHO Resolution.

Authors:  Konrad Reinhart; Ron Daniels; Niranjan Kissoon; Flavia R Machado; Raymond D Schachter; Simon Finfer
Journal:  N Engl J Med       Date:  2017-06-28       Impact factor: 91.245

Review 4.  Role of PD-1 in regulating acute infections.

Authors:  Keturah E Brown; Gordon J Freeman; E John Wherry; Arlene H Sharpe
Journal:  Curr Opin Immunol       Date:  2010-04-27       Impact factor: 7.486

Review 5.  The pathogenesis of sepsis.

Authors:  Deborah J Stearns-Kurosawa; Marcin F Osuchowski; Catherine Valentine; Shinichiro Kurosawa; Daniel G Remick
Journal:  Annu Rev Pathol       Date:  2011       Impact factor: 23.472

6.  PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsis.

Authors:  Xin Huang; Fabienne Venet; Yvonne L Wang; Alain Lepape; Zhenglong Yuan; Yaping Chen; Ryan Swan; Hakim Kherouf; Guillaume Monneret; Chun-Shiang Chung; Alfred Ayala
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-30       Impact factor: 11.205

7.  Detection of Pathogens in Blood for Diagnosis of Sepsis and Beyond.

Authors:  I Martin Sheldon
Journal:  EBioMedicine       Date:  2016-06-23       Impact factor: 8.143

8.  Serum procalcitonin in viral and bacterial meningitis.

Authors:  Usama M Alkholi; Nermin Abd Al-Monem; Ayman A Abd El-Azim; Mohamed H Sultan
Journal:  J Glob Infect Dis       Date:  2011-01

9.  Targeting the programmed cell death 1: programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis.

Authors:  Katherine Chang; Catherine Svabek; Cristina Vazquez-Guillamet; Bryan Sato; David Rasche; Strother Wilson; Paul Robbins; Nancy Ulbrandt; JoAnn Suzich; Jonathan Green; Andriani C Patera; Wade Blair; Subramaniam Krishnan; Richard Hotchkiss
Journal:  Crit Care       Date:  2014-01-04       Impact factor: 9.097

10.  Circulating programmed death-1 as a marker for sustained high hepatitis B viral load and risk of hepatocellular carcinoma.

Authors:  Hsiang-Yun Cheng; Pei-Jen Kang; Ya-Hui Chuang; Ya-Hui Wang; Meng-Chin Jan; Chih-Feng Wu; Chih-Lin Lin; Chun-Jen Liu; Yun-Fan Liaw; Shi-Ming Lin; Pei-Jer Chen; Shou-Dong Lee; Ming-Whei Yu
Journal:  PLoS One       Date:  2014-11-26       Impact factor: 3.240

View more
  2 in total

1.  Soluble PD-L1 in blood correlates positively with neutrophil and negatively with lymphocyte mRNA markers and implies adverse sepsis outcome.

Authors:  Marcus Derigs; Hendrik Heers; Susanne Lingelbach; Rainer Hofmann; Jörg Hänze
Journal:  Immunol Res       Date:  2022-06-23       Impact factor: 4.505

2.  C-Reactive Protein, Procalcitonin, and a Novel Pathogenesis and Therapeutic Target of Thrombocytopenia in Sepsis.

Authors:  Jing Li; Lijuan Hu; Lei Li
Journal:  Emerg Med Int       Date:  2022-10-08       Impact factor: 1.621

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.